Get complete Patent Opposition Report for Merck Serono

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Merck Serono against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2292252Unitary Combination Of Fsh And HcgFERRINGMay 5, 2020
EP3045471Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGDec 22, 2017

Explore Merck Serono's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2805723Jan 17, 2018Cladribine Regimen For Treating Multiple Sclerosis1
EP2164877Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production1